U.S Physical Therapy Free Cash Flow 2010-2024 | USPH

U.S Physical Therapy free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
U.S Physical Therapy Annual Free Cash Flow
2023 72.68
2022 50.29
2021 68.21
2020 92.36
2019 52.26
2018 65.81
2017 49.51
2016 42.85
2015 31.33
2014 36.27
2013 40.62
2012 35.08
2011 29.44
2010 27.77
2009 27.13
U.S Physical Therapy Quarterly Free Cash Flow
2024-03-31 2.58
2023-12-31 72.68
2023-09-30 48.07
2023-06-30 34.26
2023-03-31 9.29
2022-12-31 50.29
2022-09-30 33.95
2022-06-30 22.94
2022-03-31 9.12
2021-12-31 68.21
2021-09-30 54.51
2021-06-30 32.26
2021-03-31 16.07
2020-12-31 92.36
2020-09-30 69.11
2020-06-30 43.73
2020-03-31 13.63
2019-12-31 52.26
2019-09-30 39.10
2019-06-30 23.81
2019-03-31 11.13
2018-12-31 65.81
2018-09-30 48.70
2018-06-30 27.35
2018-03-31 14.13
2017-12-31 49.51
2017-09-30 35.32
2017-06-30 19.01
2017-03-31 12.65
2016-12-31 42.85
2016-09-30 33.42
2016-06-30 27.64
2016-03-31 12.84
2015-12-31 31.33
2015-09-30 24.24
2015-06-30 16.44
2015-03-31 1.61
2014-12-31 36.27
2014-09-30 24.96
2014-06-30 18.96
2014-03-31 2.86
2013-12-31 40.62
2013-09-30 25.85
2013-06-30 18.34
2013-03-31 3.60
2012-12-31 35.08
2012-09-30 26.40
2012-06-30 17.05
2012-03-31 4.28
2011-12-31 29.44
2011-09-30 18.17
2011-06-30 11.36
2011-03-31 4.84
2010-12-31 27.77
2010-09-30 22.01
2010-06-30 11.85
2010-03-31 5.57
2009-12-31 27.13
2009-09-30 21.29
2009-06-30 12.43
2009-03-31 4.88
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.481B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.766B 10.75
Quest Diagnostics (DGX) United States $15.676B 16.20
DaVita (DVA) United States $12.770B 15.86
Elanco Animal Health (ELAN) United States $8.767B 22.74
Encompass Health (EHC) United States $8.416B 21.54
Chemed (CHE) United States $8.316B 25.78
Option Care Health (OPCH) United States $5.192B 19.65
RadNet (RDNT) United States $4.349B 90.57
Amedisys (AMED) United States $3.005B 21.29
Astrana Health (ASTH) United States $2.367B 32.00
LifeStance Health (LFST) United States $2.106B 0.00
Addus HomeCare (ADUS) United States $1.858B 26.57
Pennant (PNTG) United States $0.696B 36.79
Aveanna Healthcare Holdings (AVAH) United States $0.496B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.041B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
Novo Integrated Sciences (NVOS) United States $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.013B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00